September 1, 2010 – The first catheter to combine near-infrared (NIR) spectroscopy with intravascular ultrasound (IVUS) to characterize coronary plaque was cleared by the U.S. Food and Drug Administration (FDA). InfraReDx Inc. received FDA 510(k) clearance to market the LipiScan IVUS Coronary Imaging System. It is designed to help cardiologists...
The first catheter to combine near-infrared (NIR) spectroscopy with intravascular ultrasound (IVUS) can help characterize coronary plaque and stent placement. The InfraReDx Inc. LipiScan IVUS Coronary Imaging System is designed to help cardiologists identify and characterize the plaques that complicate stenting and are associated with acute coronary...
Headlines
Search the Buyer's Guide
eNewsletters
Industry and technology news, conference updates and quick links to editorial features delivered to your desktop once weekly.
Late-breaking news from key medical conferences with an emphasis on technology introductions and announcements.
Be the first to know... sign up for eNews and receive breaking industry news, FDA announcements and more from our editors and partners.
Featured Video
Multimedia
None available presently.
Is radial access being used on a regular basis in your cath lab?
Print Edition
The Technology Solutions Resource for Diagnostic and Interventional Cardiology Professionals
Diagnostic & Interventional Cardiology is the widest-reaching provider of new product information, technology trends, application strategies and related connectivity solutions in the diagnostic and interventional cardiology markets.
.gif)